SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-419867
Filing Date
2014-11-20
Accepted
2014-11-20 15:49:00
Documents
3
Group Members
ASPIRE CAPITAL PARTNERS, LLCCHRISKO INVESTORS, INC.CHRISTOS KOMISSOPOULOSERIK J. BROWNRED CEDAR CAPITAL CORPSGM HOLDINGS CORP.STEVEN G. MARTIN

Document Format Files

Seq Description Document Type Size
1 SC 13G d825248dsc13g.htm SC 13G 144037
2 EX-99.1 d825248dex991.htm EX-99.1 10909
3 EX-99.2 d825248dex992.htm EX-99.2 5814
  Complete submission text file 0001193125-14-419867.txt   162583
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Subject) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53409 | Film No.: 141238939
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606
Business Address 155 NORTH WACKER DRIVE SUITE 1600 CHICAGO IL 60606 312.658.0400
Aspire Capital Fund, LLC (Filed by) CIK: 0001535683 (see all company filings)

IRS No.: 271406279
Type: SC 13G